TFAP2C and breast cancer: Down-regulation of TFAP2C in ER+ BC cells leads to epithelial to mesenchymal transition (EMT) characterized by increased VIM and CD44 expression, with decreased CDH1 and CD24 expression and decreased luminal gene (ESR1, FOXA1, GATA3) expression [127].